Archive—2008

Select articles from Center News, the newsletter for faculty & staff of the Hutchinson Center. View current news here.

   2008 - Center News highlights

• Dr. Scott Ramsey discusses cost of cancer mortality (December 15)
• Pioneering cord-blood study shared at American Society of Hematology meeting (December 8)
• Outwitting viral mimicry (December 8)
• A preliminary model for predicting malignancy (December 1)
• Study links migraines and lower breast-cancer risk (November 10)
• Larry Corey elected to Institute of Medicine (October 13)
• New guidelines for physical activity (October 13)
• New guide for breast health worldwide (October 6)
• Breast MRI scan could replace need for exploratory surgery (September 29)
• An 'HIV-test' equivalent for early detection of lung cancer (September 16)
• Study reinforces benefits of breast feeding (August 25)
• Micro molecules may mark cancer (August 4)
• The diet and diabetes dilemma (July 29)
• Hibernation drug increases survival after extreme blood loss (July 7)
• Tandem tests support earlier ovarian-cancer detection (June 23)
• Patient's cloned T cells kill tumors (June 23)
• Nurses publish myeloma guidelines (June 16)
• Uncovering the path to therapy resistance in prostate tumors (June 2)
• Adrian Ferré-D'Amaré named HHMI investigator (May 27)
• Study re-evaluation shows beneficial findings for finasteride (May 27)
• Two Center scientists win Burroughs Wellcome Fund awards (May 19)
• Researchers document rapid, dramatic 'reverse evolution' in the threespine stickleback fish (May 19)
• Center leads new Chernobyl study (May 12)
• Problems with proposed prostate-cancer treatment (May 5)
• Nobel laureate Linda Buck elected to American Academy of Arts and Sciences (May 5)
• When to wait, when to treat? (May 5)
• Paul Nghiem wins Research Scholar Grant from American Cancer Society (April 28)
• Center wins $2.2 million for solid-tumor research program (April 21)
• Pandemic flu may be well mitigated until vaccine is available (March 17)
• Health risks continue after combined menopausal hormone therapy stops (March 10)
• Even short-term combined hormone therapy use presents risks (February 25)
• What's good for the heart may be good for the prostate (February 19)
• Risky business: Mixing cancer treatment with nutritional supplements (February 11)
• Researchers confirm genetic alteration that triggers prostate cancer (February 11)
• Predicting the path of resistance (February 11)
• The troubling global trend for breast cancer (January 28)
• Lessons from evolutionary battle scars (January 28)
• Time between first period, first pregnancy affects breast-cancer risk (January 7)
• Kenyan HIV variant provides clues for vaccine design (January 7)
• Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use (January 7)